Par Drugs And Chemicals Limited has informed the Exchange regarding Re-Appointment of Mr Falgun Vallabhbhai Savani as Executive Director who retired by rotation and re-appointed in the company w.e.f. September 28, 2025.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited held its 26th Annual General Meeting on September 27, 2025, in Vadodara, Gujarat. All seven resolutions were passed with requisite majority, including the re-appointment of Mr. Falgun Vallabhbhai Savani (Chairman and Managing Director) who retired by rotation, with 93.74% votes in favour. Other key approvals included the re-appointment of statutory auditors M/s. Sarupria Somani & Associates (99.85% in favour), appointment of M/s DG Patel & Associates as Secretarial Auditors for a five-year term (FY 2025-26 to FY 2029-30), and re-appointment of Mrs. Bintal Bhaveshkumar Shah as Independent Director for a second term of five years from September 28, 2025 to September 27, 2030. The audited financial statements for FY ended March 31, 2025 were also adopted with near-unanimous support (99.99% in favour). Of 14,498 shareholders on record, 42 attended the meeting in person, and voting was conducted through both remote e-voting and ballot papers.
This is a routine AGM outcome with no material change in management or governance — existing directors and auditors were retained, and all resolutions passed comfortably. Shareholders should note continuity in leadership and oversight, with no immediate implications for the stock price.